342 related articles for article (PubMed ID: 24692724)
1. Piperine enhances the efficacy of TRAIL-based therapy for triple-negative breast cancer cells.
Abdelhamed S; Yokoyama S; Refaat A; Ogura K; Yagita H; Awale S; Saiki I
Anticancer Res; 2014 Apr; 34(4):1893-9. PubMed ID: 24692724
[TBL] [Abstract][Full Text] [Related]
2. Natural inspired piperine-based ureas and amides as novel antitumor agents towards breast cancer.
Elimam DM; Elgazar AA; El-Senduny FF; El-Domany RA; Badria FA; Eldehna WM
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):39-50. PubMed ID: 34894962
[TBL] [Abstract][Full Text] [Related]
3. Piperine derivatives as potential inhibitors of Survivin: An in silico molecular docking.
Sattarinezhad E; Bordbar AK; Fani N
Comput Biol Med; 2015 Aug; 63():219-27. PubMed ID: 26093789
[TBL] [Abstract][Full Text] [Related]
4. Piperine inhibits the growth and motility of triple-negative breast cancer cells.
Greenshields AL; Doucette CD; Sutton KM; Madera L; Annan H; Yaffe PB; Knickle AF; Dong Z; Hoskin DW
Cancer Lett; 2015 Feb; 357(1):129-140. PubMed ID: 25444919
[TBL] [Abstract][Full Text] [Related]
5. Delivery of Apoptosis-inducing Piperine to Triple-negative Breast Cancer Cells
Rad JG; Hoskin DW
Anticancer Res; 2020 Feb; 40(2):689-694. PubMed ID: 32014909
[TBL] [Abstract][Full Text] [Related]
6. Piperine impairs cell cycle progression and causes reactive oxygen species-dependent apoptosis in rectal cancer cells.
Yaffe PB; Doucette CD; Walsh M; Hoskin DW
Exp Mol Pathol; 2013 Feb; 94(1):109-14. PubMed ID: 23063564
[TBL] [Abstract][Full Text] [Related]
7. Hesperidin, piperine and bee venom synergistically potentiate the anticancer effect of tamoxifen against breast cancer cells.
Khamis AAA; Ali EMM; El-Moneim MAA; Abd-Alhaseeb MM; El-Magd MA; Salim EI
Biomed Pharmacother; 2018 Sep; 105():1335-1343. PubMed ID: 30021371
[TBL] [Abstract][Full Text] [Related]
8. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
Lu M; Strohecker A; Chen F; Kwan T; Bosman J; Jordan VC; Cryns VL
Clin Cancer Res; 2008 May; 14(10):3168-76. PubMed ID: 18483385
[TBL] [Abstract][Full Text] [Related]
9. Piperine, an alkaloid from black pepper, inhibits growth of human colon cancer cells via G1 arrest and apoptosis triggered by endoplasmic reticulum stress.
Yaffe PB; Power Coombs MR; Doucette CD; Walsh M; Hoskin DW
Mol Carcinog; 2015 Oct; 54(10):1070-85. PubMed ID: 24819444
[TBL] [Abstract][Full Text] [Related]
10. Development of core-shell nanocarrier system for augmenting piperine cytotoxic activity against human brain cancer cell line.
Sedeky AS; Khalil IA; Hefnawy A; El-Sherbiny IM
Eur J Pharm Sci; 2018 Jun; 118():103-112. PubMed ID: 29597041
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of a novel drug delivery: Soluplus
Ding Y; Wang C; Wang Y; Xu Y; Zhao J; Gao M; Ding Y; Peng J; Li L
Drug Dev Ind Pharm; 2018 Sep; 44(9):1409-1416. PubMed ID: 29718714
[TBL] [Abstract][Full Text] [Related]
12. Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus.
Kumar A; Khan IA; Koul S; Koul JL; Taneja SC; Ali I; Ali F; Sharma S; Mirza ZM; Kumar M; Sangwan PL; Gupta P; Thota N; Qazi GN
J Antimicrob Chemother; 2008 Jun; 61(6):1270-6. PubMed ID: 18334493
[TBL] [Abstract][Full Text] [Related]
13. Piperine inhibits LPS induced expression of inflammatory mediators in RAW 264.7 cells.
Ying X; Yu K; Chen X; Chen H; Hong J; Cheng S; Peng L
Cell Immunol; 2013; 285(1-2):49-54. PubMed ID: 24071564
[TBL] [Abstract][Full Text] [Related]
14. Identification of plant extracts sensitizing breast cancer cells to TRAIL.
Abdelhamed S; Yokoyama S; Hafiyani L; Kalauni SK; Hayakawa Y; Awale S; Saiki I
Oncol Rep; 2013 May; 29(5):1991-8. PubMed ID: 23426404
[TBL] [Abstract][Full Text] [Related]
15. Piperine and Celecoxib synergistically inhibit colon cancer cell proliferation via modulating Wnt/β-catenin signaling pathway.
Srivastava S; Dewangan J; Mishra S; Divakar A; Chaturvedi S; Wahajuddin M; Kumar S; Rath SK
Phytomedicine; 2021 Apr; 84():153484. PubMed ID: 33667839
[TBL] [Abstract][Full Text] [Related]
16. MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer.
Greer YE; Gilbert SF; Gril B; Narwal R; Peacock Brooks DL; Tice DA; Steeg PS; Lipkowitz S
Breast Cancer Res; 2019 Feb; 21(1):27. PubMed ID: 30777098
[TBL] [Abstract][Full Text] [Related]
17. Combination of Ad-sTRAIL with the chemotherapeutic drug cisplatin synergistically enhances their pro-apoptotic ability in human breast cancer cells.
Liu X; Wang J; Wang H; Liu S; Liang Y; Lv Z; Zhou Q; Ding W
Oncol Rep; 2013 Oct; 30(4):1913-9. PubMed ID: 23912708
[TBL] [Abstract][Full Text] [Related]
18. Antitumor and Apoptosis-inducing Effects of Piperine on Human Melanoma Cells.
Yoo ES; Choo GS; Kim SH; Woo JS; Kim HJ; Park YS; Kim BS; Kim SK; Park BK; Cho SD; Nam JS; Choi CS; Che JH; Jung JY
Anticancer Res; 2019 Apr; 39(4):1883-1892. PubMed ID: 30952729
[TBL] [Abstract][Full Text] [Related]
19. In vitro TRPV1 activity of piperine derived amides.
Correa EA; Högestätt ED; Sterner O; Echeverri F; Zygmunt PM
Bioorg Med Chem; 2010 May; 18(9):3299-306. PubMed ID: 20381363
[TBL] [Abstract][Full Text] [Related]
20. Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists by suppressing XIAP expression.
Strekalova E; Malin D; Rajanala H; Cryns VL
Breast Cancer Res Treat; 2017 Jun; 163(3):435-447. PubMed ID: 28324269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
